Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Outset Medical (OM) Cost of Revenue (2019 - 2026)

Outset Medical has reported Cost of Revenue over the past 7 years, most recently at $16.6 million for Q4 2025.

  • Quarterly Cost of Revenue rose 7.71% to $16.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $67.4 million through Dec 2025, down 8.2% year-over-year, with the annual reading at $72.7 million for FY2025, 3.82% up from the prior year.
  • Cost of Revenue was $16.6 million for Q4 2025 at Outset Medical, down from $17.8 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $28.3 million in Q2 2023 and troughed at $13.2 million in Q2 2021.
  • The 5-year median for Cost of Revenue is $20.7 million (2022), against an average of $20.5 million.
  • Year-over-year, Cost of Revenue surged 210.73% in 2021 and then crashed 36.03% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $24.8 million in 2021, then increased by 7.66% to $26.7 million in 2022, then fell by 16.98% to $22.2 million in 2023, then crashed by 30.38% to $15.5 million in 2024, then increased by 7.71% to $16.6 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Cost of Revenue are $16.6 million (Q4 2025), $17.8 million (Q3 2025), and $14.3 million (Q2 2025).